Showing 531-540 of 1560 results for "".
Clinical Evidence: Insights From Early Trials of CDH6-Targeted Therapies
https://reachmd.com/programs/cme/clinical-evidence-insights-from-early-trials-of-cdh6-targeted-therapies/37669/CDH6 in Focus: Advancing Biomarker-Driven Strategies for Platinum-Resistant Ovarian CancerMOA: CDH6-Targeted Antibody-Drug Conjugates
https://reachmd.com/programs/cme/MOA-cdh6-targeted-antibody-drug-conjugates/37668/CDH6 in Focus: Advancing Biomarker-Driven Strategies for Platinum-Resistant Ovarian CancerMapping CLL Treatment Endpoints: PFS and TTNT in Fixed vs Continuous Therapy
https://reachmd.com/programs/clinicians-roundtable/mapping-cll-treatment-endpoints-pfs-and-ttnt-in-fixed-vs-continuous-therapy/29177/Treatment selection in chronic lymphocytic leukemia (CLL) generally follows one of two strategies: fixed-duration therapy or continuous therapy. Each has different implications for long-term management and patient experience, and examining both progression-free survival (PFS) and time to next treatmSafety and Tolerability of CDH6-Directed Antibody-Drug Conjugates
https://reachmd.com/programs/cme/safety-and-tolerability-of-cdh6-directed-antibody-drug-conjugates/37865/CDH6 in Focus: Advancing Biomarker-Driven Strategies for Platinum-Resistant Ovarian CancerLooking Ahead: Integrating CDH6-Targeted Therapies Into Ovarian Cancer Treatment Paradigms
https://reachmd.com/programs/cme/looking-ahead-integrating-cdh6-targeted-therapies-into-ovarian-cancer-treatment-paradigms/37866/CDH6 in Focus: Advancing Biomarker-Driven Strategies for Platinum-Resistant Ovarian CancerHeart Healer: Pioneering Treatments for Heart Failure for Longer Life Expectancy
https://reachmd.com/programs/medical-industry-feature/heart-healer-pioneering-treatments-for-heart-failure-for-longer-life-expectancy/24445/Learn how Dr. Nir Uriel is creating a better quality of life for heart failure patients with revolutionary methods and innovative technologies.Expanding the Risk Profile: Genetic Insights Into Lung Cancer in Non-Smokers
https://reachmd.com/programs/clinicians-roundtable/program-name/36565/While smoking remains a key risk factor for lung cancer, up to 25 percent of cases occur in people who have never smoked, leaving significant gaps in our understanding of causation and diagnostics. Dr. Paola Marignani explores emerging discoveries in gene variants unique to never-smokers, uncoveredOne Emergency Physician’s Cheat Sheet to COVID-19
https://reachmd.com/programs/covid-19-frontlines/one-emergency-physicians-cheat-sheet-to-covid-19/11376/Tune in to hear an anonymous account of unpredictable COVID-19 symptoms in a small-town emergency room.Mapping the Landscape: Diagnostic Tools in Corneal Health
https://reachmd.com/programs/empower/mapping-the-landscape-diagnostic-tools-in-corneal-health/39288/Epilepsy Essentials: Ketogenic Diet Therapy Considerations in Clinical Practice
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/epilepsy-essentials-ketogenic-diet-therapy-considerations-in-clinical-practice/32092/Clinicians need to work closely with people on the ketogenic diet to manage side effects, ensure adequate nutrition, and confirm appropriate seizure control.